Nuvectis Pharma, Inc. Shares Outstanding (Cover Page)
Nuvectis Pharma, Inc. (NVCT) had Shares Outstanding (Cover Page) of 32.58 million shares as of 2026-07-31, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-31: Entity Common Stock, Shares Outstanding 32.58M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 26.53M shares.
- 2026-02-06: Entity Common Stock, Shares Outstanding 26.49M shares.
- 2025-11-01: Entity Common Stock, Shares Outstanding 25.61M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 32.58M shares 10-Q · filed 2026-08-04 |
| 2026-05-01 | 26.53M shares 10-Q · filed 2026-05-05 |
| 2026-02-06 | 26.49M shares 10-K · filed 2026-02-11 |
| 2025-11-01 | 25.61M shares 10-Q · filed 2025-11-04 |
| 2025-08-01 | 25.46M shares 10-Q · filed 2025-08-05 |
| 2025-05-01 | 23.63M shares 10-Q · filed 2025-05-06 |
| 2025-02-21 | 23.39M shares 10-K · filed 2025-02-25 |
| 2024-11-01 | 19.32M shares 10-Q · filed 2024-11-05 |
| 2024-08-02 | 18.65M shares 10-Q · filed 2024-08-06 |
| 2024-05-03 | 18.36M shares 10-Q · filed 2024-05-07 |
| 2024-03-01 | 17.77M shares 10-K · filed 2024-03-05 |
| 2023-11-07 | 17.33M shares 10-Q · filed 2023-11-08 |
| 2023-08-04 | 17.23M shares 10-Q · filed 2023-08-09 |
| 2023-05-01 | 16.01M shares 10-Q · filed 2023-05-10 |
| 2023-03-22 | 14.75M shares 10-K/A · filed 2023-03-27 |
| 2023-03-01 | 14.75M shares 10-K · filed 2023-03-08 |
| 2022-11-07 | 14.64M shares 10-Q · filed 2022-11-08 |
| 2022-08-04 | 14.64M shares 10-Q · filed 2022-08-10 |
| 2022-05-10 | 12.72M shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |